Tarsus Pharmaceuticals, Inc. financial data

Symbol
TARS on Nasdaq
Location
Irvine, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 04 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 485% % -28%
Quick Ratio 3% % -44%
Debt-to-equity 54% % 29%
Return On Equity -26% % 53%
Return On Assets -17% % 57%
Operating Margin -24% % 78%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 42,449,105 shares 11%
Common Stock, Shares, Outstanding 42,447,882 shares 11%
Entity Public Float $996,000,000 USD 117%
Common Stock, Value, Issued $6,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 42,607,717 shares 11%
Weighted Average Number of Shares Outstanding, Diluted 42,607,717 shares 11%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $366,100,000 USD 182%
Research and Development Expense $63,160,000 USD 27%
General and Administrative Expense $57,910,000 USD 91%
Costs and Expenses $453,514,000 USD 68%
Operating Income (Loss) $87,414,000 USD 38%
Nonoperating Income (Expense) $6,256,000 USD 0.02%
Net Income (Loss) Attributable to Parent $81,158,000 USD 40%
Earnings Per Share, Basic -1 USD/shares 47%
Earnings Per Share, Diluted -1 USD/shares 47%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $112,724,000 USD -36%
Marketable Securities, Current $289,113,000 USD 105%
Accounts Receivable, after Allowance for Credit Loss, Current $72,620,000 USD 149%
Inventory, Net $3,836,000 USD 35%
Assets, Current $501,704,000 USD 40%
Property, Plant and Equipment, Net $5,746,000 USD 140%
Operating Lease, Right-of-Use Asset $10,233,000 USD 468%
Intangible Assets, Net (Excluding Goodwill) $7,606,000 USD -11%
Other Assets, Noncurrent $1,177,000 USD 33%
Assets $534,561,000 USD 42%
Employee-related Liabilities, Current $13,552,000 USD 20%
Liabilities, Current $117,050,000 USD 78%
Operating Lease, Liability, Noncurrent $10,148,000 USD 718%
Other Liabilities, Noncurrent $10,148,000 USD 718%
Liabilities $199,479,000 USD 44%
Accumulated Other Comprehensive Income (Loss), Net of Tax $289,000 USD -16%
Retained Earnings (Accumulated Deficit) $418,255,000 USD -24%
Stockholders' Equity Attributable to Parent $335,082,000 USD 41%
Liabilities and Equity $534,561,000 USD 42%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $20,651,000 USD 45%
Net Cash Provided by (Used in) Financing Activities $136,562,000 USD 26%
Net Cash Provided by (Used in) Investing Activities $34,942,000 USD 66%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 42,447,882 shares 11%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $80,969,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $115,287,000 USD -35%
Interest Paid, Excluding Capitalized Interest, Operating Activities $2,074,000 USD 139%
Deferred Tax Assets, Valuation Allowance $88,043,000 USD 46%
Deferred Tax Assets, Gross $88,397,000 USD 45%
Operating Lease, Liability $10,228,000 USD 446%
Depreciation $835,000 USD 18%
Payments to Acquire Property, Plant, and Equipment $590,000 USD 239%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $81,215,000 USD 39%
Lessee, Operating Lease, Liability, to be Paid $28,488,000 USD 1154%
Property, Plant and Equipment, Gross $8,375,000 USD 101%
Operating Lease, Liability, Current $80,000 USD -87%
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,625,000 USD 164%
Lessee, Operating Lease, Liability, to be Paid, Year One $2,021,000 USD 110%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 10%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $12,417,000 USD 5184%
Lessee, Operating Lease, Liability, to be Paid, Year Three $2,704,000 USD 3158%
Deferred Tax Assets, Operating Loss Carryforwards $33,677,000 USD 30%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $4,750,000 USD 21%
Lessee, Operating Lease, Liability, to be Paid, Year Four $2,783,000 USD
Operating Lease, Payments $780,000 USD 0%
Additional Paid in Capital $753,042,000 USD 31%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $880,000 USD 103%
Deferred Tax Assets, Net of Valuation Allowance $354,000 USD -52%
Share-based Payment Arrangement, Expense $34,810,000 USD 34%
Interest Expense $3,645,000 USD 42%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%